Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM): a Multicenter Randomized Controlled Trial

NCT05848102 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT05848102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05848102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM): a Multicenter Randomized Controlled Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 4
Overall status
Unknown status
Start date
December 23, 2022
Completion date
April 23, 2025
Enrollment
166 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation